Citeline/Evaluate announced that it will exhibit at BioJapan2026. The focus will be on what the company showcases to support strategy development from drug discovery through post-launch using data, consulting and technology.
Citeline/Evaluate (Evaluate Japan Co., Ltd.) will exhibit at BioJapan2026. Through its participation, the company aims to highlight its support for strategy development at each stage of the drug discovery process.
The company states that it supports strategy development from drug discovery through post-launch by combining industry-leading data, consulting and technology.